Article Details

Ovid Therapeutics (NASDAQ:OVID) Rating Lowered to Strong Sell at ValuEngine

Retrieved on: 2020-01-09 00:39:10

Tags for this article:

Click the tags to see associated articles and topics

Ovid Therapeutics (NASDAQ:OVID) Rating Lowered to Strong Sell at ValuEngine. View article details on hiswai:

Excerpt

<div>Finally, <b>Acadian Asset Management</b> LLC boosted its holdings in Ovid Therapeutics by 37.4% in the second quarter. <b>Acadian Asset Management</b> LLC ...</div>

Article found on:

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up